title: [Clinical evaluation of 12 week salmeterol therapy in allergic asthma patients].
abstract: The purpose of the study was to evaluate the efficacy of salmeterol in asthma therapy. The study was performed on a group of 16 allergic asthma patients sensitive to house dust mite allergens. After a run-in period the patients were treated with salmeterol, 2 x 50 micrograms, for a period of 12 weeks. They noted an intensity of asthma symptoms, morning and evening PEF, beta 2-agonist consumption and adverse in their diary cards. On the visit to the clinic spirometry was performed. During the treatment a significant reduction in the symptom score, PEF variation, beta-agonist consumption and an increase in the value of morning and evening PEF were noted. The above results indicate the great efficacy of salmeterol in asthma therapy.
authors.affiliation: Kliniki Alergologii i Chorób Wewnetrznych, Akademii Medycznej w Białymstoku.
authors.forename: Z
authors.initials: Z
authors.lastname: Siergiejko
authors.forename: Z
authors.initials: Z
authors.lastname: Zietkowski
authors.forename: A
authors.initials: A
authors.lastname: Rogalewska
authors.forename: S
authors.initials: S
authors.lastname: Chyrek-Borowska
mesh_terms: D000328:Adult; D000420:Albuterol / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000818:Animals; D001249:Asthma / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D001993:Bronchodilator Agents / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D008925:Mites; D012129:Respiratory Function Tests; D012130:Respiratory Hypersensitivity / Q000150:complications; D000068299:Salmeterol Xinafoate; D016896:Treatment Outcome
chemical_list: D001993:Bronchodilator Agents; D000068299:Salmeterol Xinafoate; D000420:Albuterol